Drugs Controller General Of India

'Blood Is Not For Sale': DCGI's Big Move To Curb Overcharging By Hospitals, Blood Banks

'Himachal's Baddi Becoming 'Hub' Of Spurious Drugs': NHRC Notice To Health Ministry, DCGI And FSSAI

Licences Of 18 Pharma Firms Cancelled For Manufacturing Spurious Drugs: Report

Explained: As India Unveils SII's CERVAVAC, Know How Cervical Cancer Vaccines Work

Cervical Cancer Vaccine To Be Available In Few Months, To Be Priced Between Rs 200-400: Adar Poonawalla

SII To Launch India's First Indigenously Developed Vaccine Against Cervical Cancer Tomorrow

BREAKING | DCGI Gives Nod To Covaxin For Restricted EUA For Inoculation In Children Aged 6-12

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years

Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report

Covid Vaccine: Bharat Biotech Gets DCGI Permission For Intranasal Booster Dose Trials

Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population

SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron